-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Benralizumab in Skin Rash
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Benralizumab in Skin Rash Drug Details: Benralizumab (Fasenra) is a glyco-engineered monoclonal antibody, acts as...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Benralizumab in Rhinosinusitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Benralizumab in Rhinosinusitis Drug Details: Benralizumab (Fasenra) is a glyco-engineered monoclonal antibody, acts as an...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Benralizumab in Hypereosinophilic Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Benralizumab in Hypereosinophilic Syndrome Drug Details: Benralizumab (Fasenra) is a glyco-engineered monoclonal antibody, acts as...
-
Sector Analysis
Automotive Vehicle Light Weighting Market Trends and Analysis by Technology and Companies
Automotive Vehicle Light Weighing Market Report Overview The automotive vehicle light weighing material market is expected to grow rapidly due to new fuel economy regulations and CO2 emissions protocols. Reducing vehicle mass in vehicle structures allows automakers to meet future CO2 emission targets. This is because lowering a vehicle's weight by 100kg reduces fuel consumption by 0.5L over a 100km distance. While lighter vehicles can help to make the automotive industry more sustainable, the need for lightweight can sometimes conflict...
-
Company Profile
![]()
Gestamp Automocion SA – Company Profile
Gestamp Automocion SA (Gestamp) is a metal product company that designs, develops and manufactures metal components and structural systems for the automotive industry. The company's products portfolio includes BIW, chassis and mechanisms. Gestamp body-in-white products comprise bonnets, floors, exterior skin components, front and rear axles, couplings, pillars, roofs, rails, doors and mudguards. Its major technologies include stamping, welding and other technologies such as cold stamping, hot stamping, steel stamping, roll forming, hydroforming, welding and assembly, laser-welded blanks, patchwork blanks, and...
Add to Basket -
Product Insights
![]()
Net Present Value Model: Fasenra
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Fasenra Drug Details Benralizumab (Fasenra) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – benralizumab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry benralizumab Drug Details Benralizumab (Fasenra) is a glyco-engineered monoclonal antibody, acts as an anti...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.